MCL1 and Miyoshi myopathy: S63845 is a BH3‐mimetic that targets MCL‐1, and we have previously reported that it produces a synergistic apoptotic response when used in combination with venetoclax in AML cells and other groups have demonstrated this in MM cells [12, 13].